These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23281303)

  • 1. Non-familial cases of intellectual disability could be linked to de novo genetic mutations: studies suggest the potential of exome sequencing to diagnose causes of severe cases.
    Am J Med Genet A; 2013 Jan; 161A(1):vii-viii. PubMed ID: 23281303
    [No Abstract]   [Full Text] [Related]  

  • 2. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
    Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
    Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic exome sequencing in persons with severe intellectual disability.
    de Ligt J; Willemsen MH; van Bon BW; Kleefstra T; Yntema HG; Kroes T; Vulto-van Silfhout AT; Koolen DA; de Vries P; Gilissen C; del Rosario M; Hoischen A; Scheffer H; de Vries BB; Brunner HG; Veltman JA; Vissers LE
    N Engl J Med; 2012 Nov; 367(20):1921-9. PubMed ID: 23033978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A de novo mutation in ZMYND11, a candidate gene for 10p15.3 deletion syndrome, is associated with syndromic intellectual disability.
    Cobben JM; Weiss MM; van Dijk FS; De Reuver R; de Kruiff C; Pondaag W; Hennekam RC; Yntema HG
    Eur J Med Genet; 2014; 57(11-12):636-8. PubMed ID: 25281490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.
    Rauch A; Wieczorek D; Graf E; Wieland T; Endele S; Schwarzmayr T; Albrecht B; Bartholdi D; Beygo J; Di Donato N; Dufke A; Cremer K; Hempel M; Horn D; Hoyer J; Joset P; Röpke A; Moog U; Riess A; Thiel CT; Tzschach A; Wiesener A; Wohlleber E; Zweier C; Ekici AB; Zink AM; Rump A; Meisinger C; Grallert H; Sticht H; Schenck A; Engels H; Rappold G; Schröck E; Wieacker P; Riess O; Meitinger T; Reis A; Strom TM
    Lancet; 2012 Nov; 380(9854):1674-82. PubMed ID: 23020937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in HECW2 are associated with intellectual disability and epilepsy.
    Halvardson J; Zhao JJ; Zaghlool A; Wentzel C; Georgii-Hemming P; Månsson E; Ederth Sävmarker H; Brandberg G; Soussi Zander C; Thuresson AC; Feuk L
    J Med Genet; 2016 Oct; 53(10):697-704. PubMed ID: 27334371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SETD5 loss-of-function mutation as a likely cause of a familial syndromic intellectual disability with variable phenotypic expression.
    Szczałuba K; Brzezinska M; Kot J; Rydzanicz M; Walczak A; Stawiński P; Werner B; Płoski R
    Am J Med Genet A; 2016 Sep; 170(9):2322-7. PubMed ID: 27375234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-exome sequencing for finding de novo mutations in sporadic mental retardation.
    Robinson PN
    Genome Biol; 2010; 11(12):144. PubMed ID: 21172032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation.
    Pinto AM; Bianciardi L; Mencarelli MA; Imperatore V; Di Marco C; Furini S; Suppiej A; Salviati L; Tenconi R; Ariani F; Mari F; Renieri A
    Brain Dev; 2016 Jun; 38(6):590-6. PubMed ID: 26754451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A de novo mutation in RPL10 causes a rare X-linked ribosomopathy characterized by syndromic intellectual disability and epilepsy: A new case and review of the literature.
    Bourque DK; Hartley T; Nikkel SM; Pohl D; Tétreault M; Kernohan KD; ; Dyment DA
    Eur J Med Genet; 2018 Feb; 61(2):89-93. PubMed ID: 29066376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parent-child exome sequencing identifies a de novo truncating mutation in TCF4 in non-syndromic intellectual disability.
    Hamdan FF; Daoud H; Patry L; Dionne-Laporte A; Spiegelman D; Dobrzeniecka S; Rouleau GA; Michaud JL
    Clin Genet; 2013 Feb; 83(2):198-200. PubMed ID: 22670824
    [No Abstract]   [Full Text] [Related]  

  • 12. [Genetic diagnostics in intellectual disability: what is the benefit?].
    Willemsen MH; Kleefstra T
    Ned Tijdschr Geneeskd; 2014; 158():A8098. PubMed ID: 25406822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects.
    Willemsen MH; Vissers LE; Willemsen MA; van Bon BW; Kroes T; de Ligt J; de Vries BB; Schoots J; Lugtenberg D; Hamel BC; van Bokhoven H; Brunner HG; Veltman JA; Kleefstra T
    J Med Genet; 2012 Mar; 49(3):179-83. PubMed ID: 22368300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing SON in 21q22.11 as a cause a new syndromic form of intellectual disability: Possible contribution to Braddock-Carey syndrome phenotype.
    Takenouchi T; Miura K; Uehara T; Mizuno S; Kosaki K
    Am J Med Genet A; 2016 Oct; 170(10):2587-90. PubMed ID: 27256762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High diagnostic yield of syndromic intellectual disability by targeted next-generation sequencing.
    Martínez F; Caro-Llopis A; Roselló M; Oltra S; Mayo S; Monfort S; Orellana C
    J Med Genet; 2017 Feb; 54(2):87-92. PubMed ID: 27620904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield.
    Anazi S; Maddirevula S; Faqeih E; Alsedairy H; Alzahrani F; Shamseldin HE; Patel N; Hashem M; Ibrahim N; Abdulwahab F; Ewida N; Alsaif HS; Al Sharif H; Alamoudi W; Kentab A; Bashiri FA; Alnaser M; AlWadei AH; Alfadhel M; Eyaid W; Hashem A; Al Asmari A; Saleh MM; AlSaman A; Alhasan KA; Alsughayir M; Al Shammari M; Mahmoud A; Al-Hassnan ZN; Al-Husain M; Osama Khalil R; Abd El Meguid N; Masri A; Ali R; Ben-Omran T; El Fishway P; Hashish A; Ercan Sencicek A; State M; Alazami AM; Salih MA; Altassan N; Arold ST; Abouelhoda M; Wakil SM; Monies D; Shaheen R; Alkuraya FS
    Mol Psychiatry; 2017 Apr; 22(4):615-624. PubMed ID: 27431290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biallelic HERC1 mutations in a syndromic form of overgrowth and intellectual disability.
    Ortega-Recalde O; Beltrán OI; Gálvez JM; Palma-Montero A; Restrepo CM; Mateus HE; Laissue P
    Clin Genet; 2015 Oct; 88(4):e1-3. PubMed ID: 26138117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the genetic and clinical spectrum of the NONO-associated X-linked intellectual disability syndrome.
    Carlston CM; Bleyl SB; Andrews A; Meyers L; Brown S; Bayrak-Toydemir P; Bale JF; Botto LD
    Am J Med Genet A; 2019 May; 179(5):792-796. PubMed ID: 30773818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intellectual disability and non-compaction cardiomyopathy with a de novo NONO mutation identified by exome sequencing.
    Reinstein E; Tzur S; Cohen R; Bormans C; Behar DM
    Eur J Hum Genet; 2016 Nov; 24(11):1635-1638. PubMed ID: 27329731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome sequencing and the genetics of intellectual disability.
    Topper S; Ober C; Das S
    Clin Genet; 2011 Aug; 80(2):117-26. PubMed ID: 21627642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.